Healthline: Rates of IBD including Crohn’s Disease are three times higher than realized
UC digestive diseases expert discusses treatment options
A journalist for Healthline spoke with Loren Brook, MD, an assistant professor in the UC Department of Internal Medicine, about possible treatments for inflammatory bowel disease (IBD). In 2015, more than 3 million U.S. adults reported a diagnosis of IBD, an ongoing inflammation of all or part of the digestive tract, and includes two conditions, Crohn’s Disease and ulcerative colitis.
Brook, also a UC Health physician, explained the disease is usually lifelong but can be managed with relatively minor anti-inflammatory drugs such as oral mesalamine to immune-suppressing medications such as Remicade or steroids.
Related Stories
Cancer Center expert urges lung cancer screenings as too few at-risk patients get tested
September 4, 2026
The University of Cincinnati Cancer Center's Robert Van Haren, MD, spoke with Local 12 about the need for more awareness and discussions around lung cancer screenings.
Apply for 2027 Presidential Medal Awards
September 4, 2026
UC President Neville Pinto invites eligible students to apply for two of our university’s top awards — the PLME & PMGSE.
Selecting noninvasive tests for liver disease diagnosis, monitoring
September 3, 2026
Noninvasive tests have emerged as valuable alternatives for diagnosing, staging and monitoring MASLD and MASH, according to a recent MedCentral report.